Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC30H27F4N7S |
InChIKeyOOARMSSXPHSBDL-UHFFFAOYSA-N |
CAS Registry2768427-54-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | China | 18 Aug 2023 |





